Nanopartículas: Una prometedora alternativa para el tratamiento del cáncer de seno

Autores:: Camargo Herrera, Laura Valentina
Huérfano Santos, Lina Paola
Rondón Lagos, Sandra Milena

Tipo de recurso:: Article of journal

Fecha de publicación:: 2024

Institución:: Universidad Pedagógica y Tecnológica de Colombia

Repositorio:: RiUPTC: Repositorio Institucional UPTC

Idioma:

id	REPOUPTC2_2b319f8a5e8b235e591a3a1c217e5f95
oai_identifier_str	oai:repositorio.uptc.edu.co:001/18738
network_acronym_str	REPOUPTC2
network_name_str	RiUPTC: Repositorio Institucional UPTC
repository_id_str
dc.title.es-ES.fl_str_mv	Nanopartículas: Una prometedora alternativa para el tratamiento del cáncer de seno
title	Nanopartículas: Una prometedora alternativa para el tratamiento del cáncer de seno
spellingShingle	Nanopartículas: Una prometedora alternativa para el tratamiento del cáncer de seno Terapia dirigida, Nanotransportadores, Administración de fármacos Biotecnología Targeted therapy, Nanocarriers, Drug delivery. biotechnology
title_short	Nanopartículas: Una prometedora alternativa para el tratamiento del cáncer de seno
title_full	Nanopartículas: Una prometedora alternativa para el tratamiento del cáncer de seno
title_fullStr	Nanopartículas: Una prometedora alternativa para el tratamiento del cáncer de seno
title_full_unstemmed	Nanopartículas: Una prometedora alternativa para el tratamiento del cáncer de seno
title_sort	Nanopartículas: Una prometedora alternativa para el tratamiento del cáncer de seno
dc.creator.fl_str_mv	Camargo Herrera, Laura Valentina Huérfano Santos, Lina Paola Rondón Lagos, Sandra Milena
dc.contributor.author.spa.fl_str_mv	Camargo Herrera, Laura Valentina Huérfano Santos, Lina Paola Rondón Lagos, Sandra Milena
dc.subject.none.fl_str_mv	Terapia dirigida, Nanotransportadores, Administración de fármacos Biotecnología Targeted therapy, Nanocarriers, Drug delivery. biotechnology
topic	Terapia dirigida, Nanotransportadores, Administración de fármacos Biotecnología Targeted therapy, Nanocarriers, Drug delivery. biotechnology
publishDate	2024
dc.date.accessioned.none.fl_str_mv	2024-12-11 00:00:00 2026-04-16T17:12:31Z
dc.date.available.none.fl_str_mv	2024-12-11 00:00:00
dc.date.issued.none.fl_str_mv	2024-12-11
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.none.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.driver.none.fl_str_mv	info:eu-repo/semantics/article
dc.type.local.eng.fl_str_mv	Journal article
dc.type.version.none.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.content.none.fl_str_mv	Text
dc.type.coarversion.none.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.issn.none.fl_str_mv	0121-7488
dc.identifier.uri.none.fl_str_mv	https://repositorio.uptc.edu.co/handle/001/18738
dc.identifier.doi.none.fl_str_mv	10.19053/01217488.v15.n2.2024.16015
dc.identifier.eissn.none.fl_str_mv	2462-7658
dc.identifier.url.none.fl_str_mv	https://doi.org/10.19053/01217488.v15.n2.2024.16015
identifier_str_mv	0121-7488 10.19053/01217488.v15.n2.2024.16015 2462-7658
url	https://repositorio.uptc.edu.co/handle/001/18738 https://doi.org/10.19053/01217488.v15.n2.2024.16015
dc.language.iso.none.fl_str_mv
language_invalid_str_mv
dc.relation.references.none.fl_str_mv	Aghebati‐Maleki, A., Dolati, S., Ahmadi, M., Baghbanzhadeh, A., Asadi, M., Fotouhi, A., ... & Aghebati‐Maleki, L. (2020). Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers. Journal of cellular physiology, 235(3), 1962-1972. Anselmo A.C., Mitragotri S. An overview of clinical and commercial impact of drug delivery systems. J. Control. Release. 2014;190:15–28. doi: 10.1016/j.jconrel.2014.03.053. Aoki, H., Takada, Y., Kondo, S., Sawaya, R., Aggarwal, B. B., & Kondo, Y. (2007). Evidence That Curcumin Suppresses the Growth of Malignant Gliomas in Vitro and in Vivo through Induction of Autophagy: Role of Akt and Extracellular Signal-Regulated Kinase Signaling Pathways. Molecular Pharmacology, 72(1), 29–39. doi:10.1124/mol.106.033167 Bawarski, W. E., Chidlowsky, E., Bharali, D. J., & Mousa, S. A. (2008). Emerging nanopharmaceuticals. Nanomedicine: Nanotechnology, Biology and Medicine, 4(4), 273-282. Bazak, R., Houri, M., Achy, S. EL, Hussein, W., & Refaat, T. (2014). Passive targeting of nanoparticles to cancer: A comprehensive review of the literature. Molecular and Clinical Oncology, 2(6), 904–908. https://doi.org/10.3892/mco.2014.356 Berger, A. M., Gerber, L. H., & Mayer, D. K. (2012). Cancer-related fatigue: Implications for breast cancer survivors. Cancer, 118(SUPPL.8), 2261–2269. https://doi.org/10.1002/cncr.27475 Blanco E., Shen H., Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 2015;33:941. doi: 10.1038/nbt.3330. Brinkman, A. M., Chen, G., Wang, Y., Hedman, C. J., Sherer, N. M., Havighurst, T. C., … Xu, W. (2016). Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer. Biomaterials, 101, 20–31. doi:10.1016/j.biomaterials.2016.05.041 Canese, R., Vurro, F., & Marzola, P. (2021). Iron oxide nanoparticles as theranostic agents in cancer immunotherapy. Nanomaterials, 11(8), 1–16. https://doi.org/10.3390/nano11081950 Carrick, S., Parker, S., Thornton, C. E., Ghersi, D., Simes, J., & Wilcken, N. (2009). Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd003372.pub3 Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K., & Saltzman, W. M. (2015). A holistic approach to targeting disease with polymeric nanoparticles. Nature Reviews Drug Discovery, 14(4), 239–247. doi:10.1038/nrd4503 Esfandiari, N., Arzanani, M. K., Soleimani, M., Kohi-Habibi, M., & Svendsen, W. E. (2016). A new application of plant virus nanoparticles as drug delivery in breast cancer. Tumor Biology, 37(1), 1229-1236. Danhier F. (2016). To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine? J. Control Rel. 244(Pt A), 108–121. doi: 10.1016/j.jconrel.2016.11.015 Davis, M. E., Chen, Z., & Shin, D. M. (2008). Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature Reviews Drug Discovery, 7(9), 771–782. doi:10.1038/nrd2614 Dear, R. F., McGeechan, K., Jenkins, M. C., Barratt, A., Tattersall, M. H., & Wilcken, N. (2013). Combination versus sequential single agent chemotherapy for metastatic breast cancer. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd008792.pub2 De Sousa Marcial, S. P., Carneiro, G., & Leite, E. A. (2017). Lipid-based nanoparticles as drug delivery system for paclitaxel in breast cancer treatment. Journal of Nanoparticle Research, 19(10), 1-11. Ding, L., Li, J., Huang, R., Liu, Z., Li, C., Yao, S., … Pi, J. (2016). Salvianolic acid B protects against myocardial damage caused by nanocarrier TiO2; and synergistic anti-breast carcinoma effect with curcumin via codelivery system of folic acid-targeted and polyethylene glycol-modified TiO2 nanoparticles. International Journal of Nanomedicine, Volume 11, 5709–5727. doi:10.2147/ijn.s107767 Dhankhar, R., Vyas, S. P., Jain, A. K., Arora, S., Rath, G., & Goyal, A. K. (2010). Advances in novel drug delivery strategies for breast cancer therapy. Artificial Cells, Blood Substitutes, and Biotechnology, 38(5), 230-249. Du, M., Ouyang, Y., Meng, F., Ma, Q., Liu, H., Zhuang, Y., Pang, M., Cai, T., & Cai, Y. (2019). Nanotargeted agents: an emerging therapeutic strategy for breast cancer. Nanomedicine, 14(13), 1771–1786. https://doi.org/10.2217/nnm-2018-0481 D’souza, A. A., & Shegokar, R. (2016). Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications. Expert Opinion on Drug Delivery, 13(9), 1257–1275. doi:10.1080/17425247.2016.1182485 Gong, J., Chen, M., Zheng, Y., Wang, S., & Wang, Y. (2012). Polymeric micelles drug delivery system in oncology. Journal of Controlled Release, 159(3), 312-323. Gupta, A., Eral, H. B., Hatton, T. A., & Doyle, P. S. (2016). Nanoemulsions: formation, properties and applications. Soft Matter, 12(11), 2826–2841. doi:10.1039/c5sm02958a GLOBOCAN, & WHO. (2018). Mes de sensibilización sobre el cáncer de mama. https://www.who.int/es/news-room/fact-sheets/detail/breast-cancer Gumuskaya, B., Alper, M., Hucumenoglu, S., Altundag, K., Uner, A., & Guler, G. (2010). EGFR expression and gene copy number in triple-negative breast carcinoma. Cancer Genetics and Cytogenetics, 203(2), 222–229. doi:10.1016/j.cancergencyto.2010.07.118 Hahm, E.-R., Gho, Y. S., Park, S., Park, C., Kim, K.-W., & Yang, C.-H. (2004). Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis. Biochemical and Biophysical Research Communications, 321(2), 337–344. doi:10.1016/j.bbrc.2004.06.119 Hanafi-Bojd, M. Y., Jaafari, M. R., Ramezanian, N., Xue, M., Amin, M., Shahtahmassebi, N., & Malaekeh-Nikouei, B. (2015). Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells. European Journal of Pharmaceutics and Biopharmaceutics, 89, 248-258. Haque S.T., Karim M., Abidin S.A.Z., Othman I., Holl M.M.B., Chowdhury E.H. Fe/Mg-Modified Carbonate Apatite with Uniform Particle Size and Unique Transport Protein-Related Protein Corona Efficiently Delivers Doxorubicin into Breast Cancer Cells. Nanomaterials. 2020;10:834. doi: 10.3390/nano10050834. Jahan S, Karim ME, Chowdhury EH. Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics. Biomedicines. 2021 Jan 26;9(2):114. doi: 10.3390/biomedicines9020114. PMID: 33530291; PMCID: PMC7910939. Jarzyna, P. A., Gianella, A., Skajaa, T., Knudsen, G., Deddens, L. H., Cormode, D. P., Mulder, W. J. M. (2010). Multifunctional imaging nanoprobes. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology, 2(2), 138–150. https://doi.org/10.1002/wnan.72. Karra, N., & Benita, S. (2012). The ligand nanoparticle conjugation approach for targeted cancer therapy. Current Drug Metabolism, 13(1), 22–41. Kim, J. S., Yoon, T.-J., Yu, K. N., Kim, B. G., Park, S. J., Kim, H. W., … Cho, M. H. (2005). Toxicity and Tissue Distribution of Magnetic Nanoparticles in Mice. Toxicological Sciences, 89(1), 338–347. doi:10.1093/toxsci/kfj027 Kurmi B.D., Patel P., Paliwal R., Paliwal S.R. Molecular approaches for targeted drug delivery towards cancer: A concise review with respect to nanotechnology. J. Drug Deliv. Sci. Technol. 2020;57:101682. doi: 10.1016/j.jddst.2020.101682. Le, D. H., Lee, K. L., Shukla, S., Commandeur, U., & Steinmetz, N. F. (2017). Potato virus X, a filamentous plant viral nanoparticle for doxorubicin delivery in cancer therapy. Nanoscale, 9(6), 2348-2357. Liyanage, P. Y., Hettiarachchi, S. D., Zhou, Y., Ouhtit, A., Seven, E. S., Oztan, C. Y., Celik, E., & Leblanc, R. M. (2019). Nanoparticle-mediated targeted drug delivery for breast cancer treatment. Biochimica et Biophysica Acta - Reviews on Cancer, 1871(2), 419–433. https://doi.org/10.1016/j.bbcan.2019.04.006 Lozano-Ocaña Y, Tubón-Usca I, Vaca-Altamirano G, Tubón-Usca G. (2022). Métodos de obtención y aplicación de nanopartículas magnéticas en el tratamiento y diagnóstico del cáncer: una revisión. Rev. Acad. Colomb. Cienc. Ex. Fis. Nat. 46(178):7-26. doi: https://doi.org/10.18257/raccefyn.1560 Markman, M., & Mekhail, T. M. (2002). Paclitaxel in cancer therapy. Expert Opinion on Pharmacotherapy, 3(6), 755–766. doi:10.1517/14656566.3.6.755 Mo R., Jiang T., Gu Z. Recent progress in multidrug delivery to cancer cells by liposomes. Nanomedicine. 2014;9:1117–1120. doi: 10.2217/nnm.14.62. Mehrgou, A., & Akouchekian, M. (2016). The importance of BRCA1 and BRCA2 genes mutations in breast cancer development. Medical Journal of the Islamic Republic of Iran, 30(1), 1–12. Mejía, M., Contreras, A., & Hernández-Carrillo, M. (2020). Calidad de vida en mujeres con cáncer de mama sometidas a quimioterapia en Cali-Colombia. Biomédica, 33(4), 24. Morent, R., De Geyter, N., Desmet, T., Dubruel, P., & Leys, C. (2011). Plasma Surface Modification of Biodegradable Polymers: A Review. Plasma Processes and Polymers, 8(3), 171–190. doi:10.1002/ppap.201000153 Mo R., Jiang T., Gu Z. Recent progress in multidrug delivery to cancer cells by liposomes. Nanomedicine. 2014;9:1117–1120. doi: 10.2217/nnm.14.62. Mu, Q., Wang, H., & Zhang, M. (2017). Nanoparticles for imaging and treatment of metastatic breast cancer. In Expert Opinion on Drug Delivery (Vol. 14, Issue 1). https://doi.org/10.1080/17425247.2016.1208650 Nag O.K., Delehanty J.B. Active cellular and subcellular targeting of nanoparticles for drug delivery. Pharmaceutics. 2019;11:543. doi: 10.3390/pharmaceutics11100543. Niazvand, F., Orazizadeh, M., Khorsandi, L., Abbaspour, M., Mansouri, E., & Khodadadi, A. (2019). Effects of Quercetin-Loaded Nanoparticles on MCF-7 Human Breast Cancer Cells. Medicina, 55(4), 114. MDPI AG. http://dx.doi.org/10.3390/medicina55040114 Oropesa-Nuñez, R., & Jáuregui-Haza, U. J. (2012). Las nanopartículas como portadores de fármacos: características y perspectivas Nanoparticles as drug carriers: characteristics and perspectives. Revista CENIC ciencias biológicas, 43(3). Revia, R. A., & Zhang, M. (2016). Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: Recent advances. Materials Today, 19(3), 157–168. https://doi.org/10.1016/j.mattod.2015.08.022 Rosenblum D., Peer D. Omics-based nanomedicine: The future of personalized oncology. Cancer Lett. 2014;352:126–136. doi: 10.1016/j.canlet.2013.07.029. Salvadormorales, C., Flahaut, E., SIM, E., SLOAN, J., HGREEN, M., & SIM, R. (2006). Complement activation and protein adsorption by carbon nanotubes. Molecular Immunology, 43(3), 193–201. doi:10.1016/j.molimm.2005.02.006 Senapati, S., Mahanta, A. K., Kumar, S., & Maiti, P. (2018). Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduction and Targeted Therapy, 3, 7. https://doi.org/10.1038/s41392‐017‐0004‐3. Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005). Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature, 436(7050), 568–572. doi:10.1038/nature03794 Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017). Nanoemulsion: Concepts, development and applications in drug delivery. Journal of Controlled Release, 252, 28–49. doi:10.1016/j.jconrel.2017.03.008 Shi J., Kantoff P.W., Wooster R., Farokhzad O.C. Cancer nanomedicine: Progress, challenges and opportunities. Nat. Rev. Cancer. 2017;17:20. doi: 10.1038/nrc.2016.108. Shimada, T.; Ueda, M.; Jinno, H.; Chiba, N.; Wada, M.; Watanabe, J. (2010). Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles. Anticancer Res. 29, 1009–1014. Soussan E., Cassel S., Blanzat M., Rico-Lattes I. Drug delivery by soft matter: Matrix and vesicular carriers. Angew. Chem. Int. Ed. 2010;48:274–288. doi: 10.1002/anie.200802453. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660 Wang, A. Z., Gu, F., Zhang, L., Chan, J. M., Radovic-Moreno, A., Shaikh, M. R., & Farokhzad, O. C. (2008). Biofunctionalized targeted nanoparticles for therapeutic applications. Expert Opinion on Biological Therapy, 8(8), 1063–1070. doi:10.1517/14712598.8.8.1063 Wang, Z., Luo, P., Dai, S., Liu, Z., Zheng, X., & Chen, T. (2013). Salvianolic Acid B Induces Apoptosis in Human Glioma U87 Cells Through p38-Mediated ROS Generation. Cellular and Molecular Neurobiology, 33(7), 921–928. doi:10.1007/s10571-013-9958-z Wilhelm S., Tavares A.J., Dai Q., Ohta S., Audet J., Dvorak H.F., Chan W.C.W. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 2016;1:1–12. doi: 10.1038/natrevmats.2016.14. World health organization, International agency for research on cancer, G. cancer observatory. (2020). Cancer today view colombia. https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=cancer&mode_population=continents&population=900&populations=170&key=total&sex=0&cancer=39&type=2&statistic=5&prevalence=1&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&half_pie=0&donut=0#collapse-group-0-1 Xiang D, Shigdar S, Qiao G et al. (2015). Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine. Theranostics 5(1), 23–42. doi: 10.7150/thno.10202 Xu H, Aguilar ZP, Yang L et al. (2011) Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood.Biomaterials 32(36), 9758–9765 Xu, X., Qin, J., & Liu, W. (2014). Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of PI3K/Akt signaling pathway. Gene, 546(2), 226–232. doi:10.1016/j.gene.2014.06.006 Xu, Z. (2015). Design of protein nanoparticles for cell targeting and blood brain barrier crossing. Universitat Autònoma de Barcelona,. Yan, Q. L., Gozin, M., Zhao, F. Q., Cohen, A., & Pang, S. P. (2016). Highly energetic compositions based on functionalized carbon nanomaterials. Nanoscale, 8(9), 4799-4851. Yang FF, Huang W, Li YF, et al. (2013). Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles, Biomaterials;22:5689-5699. Yu, D.-H., Lu, Q., Xie, J., Fang, C., & Chen, H.-Z. (2010). Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Biomaterials, 31(8), 2278–2292. doi:10.1016/j.biomaterials.2009.11.047 Zhu, W., Lee, S.-J., Castro, N. J., Yan, D., Keidar, M., & Zhang, L. G. (2016). Synergistic Effect of Cold Atmospheric Plasma and Drug Loaded Core-shell Nanoparticles on Inhibiting Breast Cancer Cell Growth. Scientific Reports, 6(1). doi:10.1038/srep21974
dc.relation.citationendpage.none.fl_str_mv	42
dc.relation.citationissue.spa.fl_str_mv	2
dc.relation.citationstartpage.none.fl_str_mv	32
dc.relation.citationvolume.spa.fl_str_mv	15
dc.relation.ispartofjournal.spa.fl_str_mv	Ciencia en Desarrollo
dc.relation.bitstream.none.fl_str_mv	https://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/download/16015/14824
dc.relation.citationedition.spa.fl_str_mv	Núm. 2 , Año 2024 : Vol. 15 Núm. 2 (2024): Vol 15, Núm.2 (2024): Julio-Diciembre
dc.rights.uri.none.fl_str_mv	https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rights.accessrights.none.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.coar.none.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.none.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Universidad Pedagógica y Tecnológica de Colombia
dc.source.none.fl_str_mv	https://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/view/16015
institution	Universidad Pedagógica y Tecnológica de Colombia
bitstream.url.fl_str_mv	https://repositorio.uptc.edu.co/bitstreams/a1a29a42-67f7-4675-9596-d02a5a6a0a12/download
bitstream.checksum.fl_str_mv	f46302a2a73a73d316547f2fd4be2b5c
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Institucional UPTC
repository.mail.fl_str_mv	bdigital@metabiblioteca.com
_version_	1881673972807892992
spelling	Camargo Herrera, Laura ValentinaHuérfano Santos, Lina PaolaRondón Lagos, Sandra Milena2024-12-11 00:00:002026-04-16T17:12:31Z2024-12-11 00:00:002024-12-110121-7488https://repositorio.uptc.edu.co/handle/001/1873810.19053/01217488.v15.n2.2024.160152462-7658https://doi.org/10.19053/01217488.v15.n2.2024.16015application/pdfUniversidad Pedagógica y Tecnológica de Colombiahttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.esinfo:eu-repo/semantics/openAccessEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.http://purl.org/coar/access_right/c_abf2https://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/view/16015Terapia dirigida, Nanotransportadores, Administración de fármacosBiotecnologíaTargeted therapy, Nanocarriers, Drug delivery.biotechnologyNanopartículas: Una prometedora alternativa para el tratamiento del cáncer de senoArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleJournal articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a85Aghebati‐Maleki, A., Dolati, S., Ahmadi, M., Baghbanzhadeh, A., Asadi, M., Fotouhi, A., ... & Aghebati‐Maleki, L. (2020). Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers. Journal of cellular physiology, 235(3), 1962-1972.Anselmo A.C., Mitragotri S. An overview of clinical and commercial impact of drug delivery systems. J. Control. Release. 2014;190:15–28. doi: 10.1016/j.jconrel.2014.03.053.Aoki, H., Takada, Y., Kondo, S., Sawaya, R., Aggarwal, B. B., & Kondo, Y. (2007). Evidence That Curcumin Suppresses the Growth of Malignant Gliomas in Vitro and in Vivo through Induction of Autophagy: Role of Akt and Extracellular Signal-Regulated Kinase Signaling Pathways. Molecular Pharmacology, 72(1), 29–39. doi:10.1124/mol.106.033167Bawarski, W. E., Chidlowsky, E., Bharali, D. J., & Mousa, S. A. (2008). Emerging nanopharmaceuticals. Nanomedicine: Nanotechnology, Biology and Medicine, 4(4), 273-282.Bazak, R., Houri, M., Achy, S. EL, Hussein, W., & Refaat, T. (2014). Passive targeting of nanoparticles to cancer: A comprehensive review of the literature. Molecular and Clinical Oncology, 2(6), 904–908. https://doi.org/10.3892/mco.2014.356Berger, A. M., Gerber, L. H., & Mayer, D. K. (2012). Cancer-related fatigue: Implications for breast cancer survivors. Cancer, 118(SUPPL.8), 2261–2269. https://doi.org/10.1002/cncr.27475Blanco E., Shen H., Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 2015;33:941. doi: 10.1038/nbt.3330.Brinkman, A. M., Chen, G., Wang, Y., Hedman, C. J., Sherer, N. M., Havighurst, T. C., … Xu, W. (2016). Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer. Biomaterials, 101, 20–31. doi:10.1016/j.biomaterials.2016.05.041Canese, R., Vurro, F., & Marzola, P. (2021). Iron oxide nanoparticles as theranostic agents in cancer immunotherapy. Nanomaterials, 11(8), 1–16. https://doi.org/10.3390/nano11081950Carrick, S., Parker, S., Thornton, C. E., Ghersi, D., Simes, J., & Wilcken, N. (2009). Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd003372.pub3Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K., & Saltzman, W. M. (2015). A holistic approach to targeting disease with polymeric nanoparticles. Nature Reviews Drug Discovery, 14(4), 239–247. doi:10.1038/nrd4503Esfandiari, N., Arzanani, M. K., Soleimani, M., Kohi-Habibi, M., & Svendsen, W. E. (2016). A new application of plant virus nanoparticles as drug delivery in breast cancer. Tumor Biology, 37(1), 1229-1236.Danhier F. (2016). To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine? J. Control Rel. 244(Pt A), 108–121. doi: 10.1016/j.jconrel.2016.11.015Davis, M. E., Chen, Z., & Shin, D. M. (2008). Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature Reviews Drug Discovery, 7(9), 771–782. doi:10.1038/nrd2614Dear, R. F., McGeechan, K., Jenkins, M. C., Barratt, A., Tattersall, M. H., & Wilcken, N. (2013). Combination versus sequential single agent chemotherapy for metastatic breast cancer. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd008792.pub2De Sousa Marcial, S. P., Carneiro, G., & Leite, E. A. (2017). Lipid-based nanoparticles as drug delivery system for paclitaxel in breast cancer treatment. Journal of Nanoparticle Research, 19(10), 1-11.Ding, L., Li, J., Huang, R., Liu, Z., Li, C., Yao, S., … Pi, J. (2016). Salvianolic acid B protects against myocardial damage caused by nanocarrier TiO2; and synergistic anti-breast carcinoma effect with curcumin via codelivery system of folic acid-targeted and polyethylene glycol-modified TiO2 nanoparticles. International Journal of Nanomedicine, Volume 11, 5709–5727. doi:10.2147/ijn.s107767Dhankhar, R., Vyas, S. P., Jain, A. K., Arora, S., Rath, G., & Goyal, A. K. (2010). Advances in novel drug delivery strategies for breast cancer therapy. Artificial Cells, Blood Substitutes, and Biotechnology, 38(5), 230-249.Du, M., Ouyang, Y., Meng, F., Ma, Q., Liu, H., Zhuang, Y., Pang, M., Cai, T., & Cai, Y. (2019). Nanotargeted agents: an emerging therapeutic strategy for breast cancer. Nanomedicine, 14(13), 1771–1786. https://doi.org/10.2217/nnm-2018-0481D’souza, A. A., & Shegokar, R. (2016). Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications. Expert Opinion on Drug Delivery, 13(9), 1257–1275. doi:10.1080/17425247.2016.1182485Gong, J., Chen, M., Zheng, Y., Wang, S., & Wang, Y. (2012). Polymeric micelles drug delivery system in oncology. Journal of Controlled Release, 159(3), 312-323.Gupta, A., Eral, H. B., Hatton, T. A., & Doyle, P. S. (2016). Nanoemulsions: formation, properties and applications. Soft Matter, 12(11), 2826–2841. doi:10.1039/c5sm02958aGLOBOCAN, & WHO. (2018). Mes de sensibilización sobre el cáncer de mama. https://www.who.int/es/news-room/fact-sheets/detail/breast-cancerGumuskaya, B., Alper, M., Hucumenoglu, S., Altundag, K., Uner, A., & Guler, G. (2010). EGFR expression and gene copy number in triple-negative breast carcinoma. Cancer Genetics and Cytogenetics, 203(2), 222–229. doi:10.1016/j.cancergencyto.2010.07.118Hahm, E.-R., Gho, Y. S., Park, S., Park, C., Kim, K.-W., & Yang, C.-H. (2004). Synthetic curcumin analogs inhibit activator protein-1 transcription and tumor-induced angiogenesis. Biochemical and Biophysical Research Communications, 321(2), 337–344. doi:10.1016/j.bbrc.2004.06.119Hanafi-Bojd, M. Y., Jaafari, M. R., Ramezanian, N., Xue, M., Amin, M., Shahtahmassebi, N., & Malaekeh-Nikouei, B. (2015). Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells. European Journal of Pharmaceutics and Biopharmaceutics, 89, 248-258.Haque S.T., Karim M., Abidin S.A.Z., Othman I., Holl M.M.B., Chowdhury E.H. Fe/Mg-Modified Carbonate Apatite with Uniform Particle Size and Unique Transport Protein-Related Protein Corona Efficiently Delivers Doxorubicin into Breast Cancer Cells. Nanomaterials. 2020;10:834. doi: 10.3390/nano10050834.Jahan S, Karim ME, Chowdhury EH. Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics. Biomedicines. 2021 Jan 26;9(2):114. doi: 10.3390/biomedicines9020114. PMID: 33530291; PMCID: PMC7910939.Jarzyna, P. A., Gianella, A., Skajaa, T., Knudsen, G., Deddens, L. H., Cormode, D. P., Mulder, W. J. M. (2010). Multifunctional imaging nanoprobes. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology, 2(2), 138–150. https://doi.org/10.1002/wnan.72.Karra, N., & Benita, S. (2012). The ligand nanoparticle conjugation approach for targeted cancer therapy. Current Drug Metabolism, 13(1), 22–41.Kim, J. S., Yoon, T.-J., Yu, K. N., Kim, B. G., Park, S. J., Kim, H. W., … Cho, M. H. (2005). Toxicity and Tissue Distribution of Magnetic Nanoparticles in Mice. Toxicological Sciences, 89(1), 338–347. doi:10.1093/toxsci/kfj027Kurmi B.D., Patel P., Paliwal R., Paliwal S.R. Molecular approaches for targeted drug delivery towards cancer: A concise review with respect to nanotechnology. J. Drug Deliv. Sci. Technol. 2020;57:101682. doi: 10.1016/j.jddst.2020.101682.Le, D. H., Lee, K. L., Shukla, S., Commandeur, U., & Steinmetz, N. F. (2017). Potato virus X, a filamentous plant viral nanoparticle for doxorubicin delivery in cancer therapy. Nanoscale, 9(6), 2348-2357.Liyanage, P. Y., Hettiarachchi, S. D., Zhou, Y., Ouhtit, A., Seven, E. S., Oztan, C. Y., Celik, E., & Leblanc, R. M. (2019). Nanoparticle-mediated targeted drug delivery for breast cancer treatment. Biochimica et Biophysica Acta - Reviews on Cancer, 1871(2), 419–433. https://doi.org/10.1016/j.bbcan.2019.04.006Lozano-Ocaña Y, Tubón-Usca I, Vaca-Altamirano G, Tubón-Usca G. (2022). Métodos de obtención y aplicación de nanopartículas magnéticas en el tratamiento y diagnóstico del cáncer: una revisión. Rev. Acad. Colomb. Cienc. Ex. Fis. Nat. 46(178):7-26. doi: https://doi.org/10.18257/raccefyn.1560Markman, M., & Mekhail, T. M. (2002). Paclitaxel in cancer therapy. Expert Opinion on Pharmacotherapy, 3(6), 755–766. doi:10.1517/14656566.3.6.755Mo R., Jiang T., Gu Z. Recent progress in multidrug delivery to cancer cells by liposomes. Nanomedicine. 2014;9:1117–1120. doi: 10.2217/nnm.14.62.Mehrgou, A., & Akouchekian, M. (2016). The importance of BRCA1 and BRCA2 genes mutations in breast cancer development. Medical Journal of the Islamic Republic of Iran, 30(1), 1–12.Mejía, M., Contreras, A., & Hernández-Carrillo, M. (2020). Calidad de vida en mujeres con cáncer de mama sometidas a quimioterapia en Cali-Colombia. Biomédica, 33(4), 24.Morent, R., De Geyter, N., Desmet, T., Dubruel, P., & Leys, C. (2011). Plasma Surface Modification of Biodegradable Polymers: A Review. Plasma Processes and Polymers, 8(3), 171–190. doi:10.1002/ppap.201000153Mo R., Jiang T., Gu Z. Recent progress in multidrug delivery to cancer cells by liposomes. Nanomedicine. 2014;9:1117–1120. doi: 10.2217/nnm.14.62.Mu, Q., Wang, H., & Zhang, M. (2017). Nanoparticles for imaging and treatment of metastatic breast cancer. In Expert Opinion on Drug Delivery (Vol. 14, Issue 1). https://doi.org/10.1080/17425247.2016.1208650Nag O.K., Delehanty J.B. Active cellular and subcellular targeting of nanoparticles for drug delivery. Pharmaceutics. 2019;11:543. doi: 10.3390/pharmaceutics11100543.Niazvand, F., Orazizadeh, M., Khorsandi, L., Abbaspour, M., Mansouri, E., & Khodadadi, A. (2019). Effects of Quercetin-Loaded Nanoparticles on MCF-7 Human Breast Cancer Cells. Medicina, 55(4), 114. MDPI AG. http://dx.doi.org/10.3390/medicina55040114Oropesa-Nuñez, R., & Jáuregui-Haza, U. J. (2012). Las nanopartículas como portadores de fármacos: características y perspectivas Nanoparticles as drug carriers: characteristics and perspectives. Revista CENIC ciencias biológicas, 43(3).Revia, R. A., & Zhang, M. (2016). Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: Recent advances. Materials Today, 19(3), 157–168. https://doi.org/10.1016/j.mattod.2015.08.022Rosenblum D., Peer D. Omics-based nanomedicine: The future of personalized oncology. Cancer Lett. 2014;352:126–136. doi: 10.1016/j.canlet.2013.07.029.Salvadormorales, C., Flahaut, E., SIM, E., SLOAN, J., HGREEN, M., & SIM, R. (2006). Complement activation and protein adsorption by carbon nanotubes. Molecular Immunology, 43(3), 193–201. doi:10.1016/j.molimm.2005.02.006Senapati, S., Mahanta, A. K., Kumar, S., & Maiti, P. (2018). Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduction and Targeted Therapy, 3, 7. https://doi.org/10.1038/s41392‐017‐0004‐3.Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., & Sasisekharan, R. (2005). Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature, 436(7050), 568–572. doi:10.1038/nature03794Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017). Nanoemulsion: Concepts, development and applications in drug delivery. Journal of Controlled Release, 252, 28–49. doi:10.1016/j.jconrel.2017.03.008Shi J., Kantoff P.W., Wooster R., Farokhzad O.C. Cancer nanomedicine: Progress, challenges and opportunities. Nat. Rev. Cancer. 2017;17:20. doi: 10.1038/nrc.2016.108.Shimada, T.; Ueda, M.; Jinno, H.; Chiba, N.; Wada, M.; Watanabe, J. (2010). Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles. Anticancer Res. 29, 1009–1014.Soussan E., Cassel S., Blanzat M., Rico-Lattes I. Drug delivery by soft matter: Matrix and vesicular carriers. Angew. Chem. Int. Ed. 2010;48:274–288. doi: 10.1002/anie.200802453.Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660Wang, A. Z., Gu, F., Zhang, L., Chan, J. M., Radovic-Moreno, A., Shaikh, M. R., & Farokhzad, O. C. (2008). Biofunctionalized targeted nanoparticles for therapeutic applications. Expert Opinion on Biological Therapy, 8(8), 1063–1070. doi:10.1517/14712598.8.8.1063Wang, Z., Luo, P., Dai, S., Liu, Z., Zheng, X., & Chen, T. (2013). Salvianolic Acid B Induces Apoptosis in Human Glioma U87 Cells Through p38-Mediated ROS Generation. Cellular and Molecular Neurobiology, 33(7), 921–928. doi:10.1007/s10571-013-9958-zWilhelm S., Tavares A.J., Dai Q., Ohta S., Audet J., Dvorak H.F., Chan W.C.W. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 2016;1:1–12. doi: 10.1038/natrevmats.2016.14.World health organization, International agency for research on cancer, G. cancer observatory. (2020). Cancer today view colombia. https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=cancer&mode_population=continents&population=900&populations=170&key=total&sex=0&cancer=39&type=2&statistic=5&prevalence=1&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&half_pie=0&donut=0#collapse-group-0-1Xiang D, Shigdar S, Qiao G et al. (2015). Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine. Theranostics 5(1), 23–42. doi: 10.7150/thno.10202Xu H, Aguilar ZP, Yang L et al. (2011) Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood.Biomaterials 32(36), 9758–9765Xu, X., Qin, J., & Liu, W. (2014). Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of PI3K/Akt signaling pathway. Gene, 546(2), 226–232. doi:10.1016/j.gene.2014.06.006Xu, Z. (2015). Design of protein nanoparticles for cell targeting and blood brain barrier crossing. Universitat Autònoma de Barcelona,.Yan, Q. L., Gozin, M., Zhao, F. Q., Cohen, A., & Pang, S. P. (2016). Highly energetic compositions based on functionalized carbon nanomaterials. Nanoscale, 8(9), 4799-4851.Yang FF, Huang W, Li YF, et al. (2013). Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles, Biomaterials;22:5689-5699.Yu, D.-H., Lu, Q., Xie, J., Fang, C., & Chen, H.-Z. (2010). Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Biomaterials, 31(8), 2278–2292. doi:10.1016/j.biomaterials.2009.11.047Zhu, W., Lee, S.-J., Castro, N. J., Yan, D., Keidar, M., & Zhang, L. G. (2016). Synergistic Effect of Cold Atmospheric Plasma and Drug Loaded Core-shell Nanoparticles on Inhibiting Breast Cancer Cell Growth. Scientific Reports, 6(1). doi:10.1038/srep219744223215Ciencia en Desarrollohttps://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/download/16015/14824Núm. 2 , Año 2024 : Vol. 15 Núm. 2 (2024): Vol 15, Núm.2 (2024): Julio-DiciembrePublicationOREORE.xmltext/xml2727https://repositorio.uptc.edu.co/bitstreams/a1a29a42-67f7-4675-9596-d02a5a6a0a12/downloadf46302a2a73a73d316547f2fd4be2b5cMD51falseAnonymousREAD001/18738oai:repositorio.uptc.edu.co:001/187382026-10-30 07:03:10.533https://creativecommons.org/licenses/by-nc-nd/4.0/deed.esmetadata.onlyhttps://repositorio.uptc.edu.coRepositorio Institucional UPTCbdigital@metabiblioteca.com

Nanopartículas: Una prometedora alternativa para el tratamiento del cáncer de seno

Publicaciones similares